<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We previously showed that complex karyotypes (CK) and chromosome 13q abnormalities have an adverse prognostic impact in childhood Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo>/<z:hpo ids='HP_0001909'>leukemias</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of our study was to identify recurrent alterations associated with MYC rearrangements in aggressive B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with CK </plain></SENT>
<SENT sid="2" pm="."><plain>Multicolor fluorescence in situ hybridization (M-FISH) was performed in 84 patient samples (59 adults and 25 children), including 37 BL (13 <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and 24 <z:hpo ids='HP_0002488'>acute leukemias</z:hpo>), 12 DLBCL, 28 B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with intermediate features (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), 4 B-cell precursor <z:hpo ids='HP_0006721'>acute lymphoblastic leukemias</z:hpo> (BCP-ALL), and 3 unclassifiable B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>New (cytogenetically undetected) abnormalities were identified in 80% of patients </plain></SENT>
<SENT sid="4" pm="."><plain>We also refined one-third of the chromosomal aberrations detected by karyotyping </plain></SENT>
<SENT sid="5" pm="."><plain>M-FISH proved to be more useful in identifying chromosomal partners involved in unbalanced translocations and in revealing greater complexity of 13q rearrangements </plain></SENT>
<SENT sid="6" pm="."><plain>Most of the newly identified or refined recurrent alterations involved 1q, 13q and 3q (gains/losses), 7q and 18q (gains), or 6q (losses), suggesting that these secondary aberrations may play a role in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Several patterns of genomic aberrations were identified: 1q gains in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, <z:mp ids='MP_0004027'>trisomies</z:mp> 7 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, and 18q-translocations in adult non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>BCP-ALL usually displayed an 18q21 rearrangement </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> karyotypes were less complex and aneuploid than those of other MYC-rearranged <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>BCP-ALL and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> were associated with a higher rate of early <z:hpo ids='HP_0011420'>death</z:hpo> than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>These findings support the categorization of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> as a distinct entity and suggest that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> with CK are indeed different from other aggressive MYC-rearranged <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, which usually show greater genetic complexity. Â© 2012 Wiley Periodicals, Inc </plain></SENT>
</text></document>